statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	513
SG - Singapore	318
CN - Cina	231
FI - Finlandia	88
HK - Hong Kong	83
VN - Vietnam	78
BR - Brasile	60
IT - Italia	49
ES - Italia	45
BD - Bangladesh	38
KR - Corea	37
GB - Regno Unito	29
RU - Federazione Russa	24
IN - India	23
DE - Germania	19
FR - Francia	17
AR - Argentina	11
CA - Canada	11
AT - Austria	9
IQ - Iraq	9
JP - Giappone	9
IE - Irlanda	5
NL - Olanda	5
PY - Paraguay	5
BE - Belgio	4
ID - Indonesia	4
MX - Messico	4
PL - Polonia	4
BY - Bielorussia	3
LT - Lituania	3
MA - Marocco	3
ZA - Sudafrica	3
CL - Cile	2
CO - Colombia	2
EC - Ecuador	2
IL - Israele	2
JO - Giordania	2
NI - Nicaragua	2
PK - Pakistan	2
SA - Arabia Saudita	2
SK - Slovacchia (Repubblica Slovacca)	2
UA - Ucraina	2
BH - Bahrain	1
CR - Costa Rica	1
CZ - Repubblica Ceca	1
EG - Egitto	1
GA - Gabon	1
GR - Grecia	1
KE - Kenya	1
KG - Kirghizistan	1
KH - Cambogia	1
LU - Lussemburgo	1
LV - Lettonia	1
MD - Moldavia	1
NG - Nigeria	1
PH - Filippine	1
PS - Palestinian Territory	1
PT - Portogallo	1
SE - Svezia	1
SV - El Salvador	1
TN - Tunisia	1
TW - Taiwan	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	1.786

Nome	#
Safety of PARP inhibitors as maintenance therapy in ovarian cancer	271
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer	237
Clinical Impact of COVID-19 in a Single-Center Cohort of a Prospective Study in Cancer Patients Receiving Immunotherapy	182
Review on radiological evolution of COVID-19 pneumonia using computed tomography	154
The role of immunotherapy treatment in non-clear cell renal cell carcinoma: An analysis of the literature	146
Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study	146
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy	143
Differential diagnosis of COVID-19 at the chest computed tomography scan: A review with special focus on cancer patients	137
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents	137
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC	126
Renal cell carcinoma and viral infections: A dangerous relationship?	118
Totale	1.797

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2024/2025	582	0	0	19	36	100	78	46	41	71	19	91	81
2025/2026	1.177	92	54	97	153	119	71	166	61	160	75	58	71
2026/2027	38	38	0	0	0	0	0	0	0	0	0	0	0
Totale													1.797